Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Pregnant Women With PCOS
NCT03259919Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Oct 2000
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Norwegian University of Science and Technology. Primary endpoints: Dehydroepiandrosterone sulfate, Androstenedione and 3 more. Started Oct 2000; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03259919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03259919.